Stem Cell Research by Department of Pathology Faculty Receives Continued Support

A number of investigators from the NYU Department of Pathology are among those who will continue to receive support through research grants by the New York Stem Cell Science foundation or NYSTEM. NYSTEM was established to support stem cell research and its revolutionary clinical and promising therapeutic potential in the State of New York. Under the direction of Ruth Lehmann, Ph.D., the Laura and Isaac Perlmutter Professor of Cell Biology and Director of the Kimmel Center for Stem Cell Biology, the Kimmel Center received more than $5 million in funded 2008 NYSTEM applications and RFA-IIRP grants for projects related to stem cell research. The following members of the Department and their laboratory groups are part of the collaborative efforts funded at the Kimmel Center: Dr. Eva Hernando, Assistant Professor of Pathology, for the study of cell of origin and cancer stem cell of melanoma; Dr. Jane Hubbard, Associate Professor of Pathology, for stem cell niche formation in the C. elegans gonad, and Dr. David Levy, Dr. Louis A. Schneider Professor of Molecular Pathology and Vice Chair for Science and Professor of Microbiology, for derivation and characterization of dendritic cell lineages from hematopoietic stem cells. This support builds on a previous $1 million grant by NYSTEM to the Kimmel Center for the development of stem cell research, which included individual funds designated for the labs of Department of Pathology faculty Iannis Aifantis, Eva Hernando, Jane Hubbard, and David Levy, and core equipment funds for Peter Lopez, among 36 other researchers in the "NYU Stem Cell Group" from various programs and departments at the NYU School of Medicine and the NYU Langone Medical Center.